Literature DB >> 12939575

Branch retinal vein occlusion.

Milan R Patel1, L Michael Prisant, Dennis M Marcus.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12939575      PMCID: PMC8099289          DOI: 10.1111/j.1524-6175.2003.02469.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  16 in total

1.  The fellow eye in retinal vein occlusive disease.

Authors:  A Pollack; S Dottan; M Oliver
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

2.  Branch retinal vein occlusion. Axial length and other risk factors.

Authors:  B D Simons; A J Brucker
Journal:  Retina       Date:  1997       Impact factor: 4.256

3.  Significance of refractive status in branch retinal vein occlusion. A case-control study.

Authors:  A B Majji; M Janarthanan; T J Naduvilath
Journal:  Retina       Date:  1997       Impact factor: 4.256

4.  Risk factors of branch retinal vein occlusion.

Authors:  R L Johnston; A J Brucker; W Steinmann; M E Hoffman; J H Holmes
Journal:  Arch Ophthalmol       Date:  1985-12

Review 5.  Systemic disorders associated with retinal vascular occlusion.

Authors:  F M Recchia; G C Brown
Journal:  Curr Opin Ophthalmol       Date:  2000-12       Impact factor: 3.761

6.  Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1984-09-15       Impact factor: 5.258

Review 7.  Management of retinal vein occlusion.

Authors:  J M Keenan; E E Kritzinger; P M Dodson
Journal:  Br J Hosp Med       Date:  1993 Feb 17-Mar 2

8.  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-01

9.  Relation between retinal vein occlusions and axial length.

Authors:  N Aritürk; Y Oge; D Erkan; Y Süllü; F Mohajerý
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

10.  Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.